SBDS: A Protein Regulating Protein Stability and Degradation (G51119)

Target Name: SBDS

NCBI ID: G51119

SBDS

SBDS: A Protein Regulating Protein Stability and Degradation

SBDS (SDO1) is a protein that is expressed in the endoplasmic reticulum (ER) and is involved in the regulation of protein stability. It is a 25kDa protein that is composed of two heavy chains and two light chains. The heavy chains contain a variable region that is involved in protein-protein interactions and the light chains contain a variable region that is involved in protein-protein interactions.

SBDS is a key regulator of protein stability and is involved in the regulation of a wide range of cellular processes. It is a negative regulator of the protein degradation pathway and is involved in the maintenance of protein stability in the endoplasmic reticulum.

SBDS is a protein that has been identified as a potential drug target (or biomarker) for the treatment of a wide range of diseases. Studies have shown that SBDS is involved in the regulation of a wide range of cellular processes and is involved in the development of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key functions of SBDS is its role in the regulation of protein stability. SBDS is involved in the formation of protein-protein interactions and in the regulation of protein stability, which is important for the proper functioning of cells.

SBDS is also involved in the regulation of the degradation of proteins. It is a negative regulator of the protein degradation pathway and is involved in the maintenance of protein stability in the endoplasmic reticulum. This is important for the survival of proteins that are involved in cellular processes and for the regulation of cellular processes.

SBDS is also involved in the regulation of cellular signaling pathways. It is a component of several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These pathways are involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation.

SBDS is also involved in the regulation of gene expression. It is a negative regulator of gene expression and is involved in the regulation of the translation of mRNAs into proteins. This is important for the regulation of cellular processes and for the development of diseases.

SBDS is also involved in the regulation of cellular interactions. It is a component of several cellular interactions, including the interaction between cells and the extracellular matrix (ECM). This is important for the regulation of cellular processes and for the development of diseases.

In conclusion, SBDS is a protein that is involved in the regulation of protein stability, the degradation of proteins, cellular signaling pathways, gene expression, and cellular interactions. It is a potential drug target (or biomarker) for the treatment of a wide range of diseases and is an important protein that should be further studied.

Protein Name: SBDS Ribosome Maturation Factor

Functions: Required for the assembly of mature ribosomes and ribosome biogenesis. Together with EFL1, triggers the GTP-dependent release of EIF6 from 60S pre-ribosomes in the cytoplasm, thereby activating ribosomes for translation competence by allowing 80S ribosome assembly and facilitating EIF6 recycling to the nucleus, where it is required for 60S rRNA processing and nuclear export. Required for normal levels of protein synthesis. May play a role in cellular stress resistance. May play a role in cellular response to DNA damage. May play a role in cell proliferation

The "SBDS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SBDS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets